CPSF3 inhibition blocks pancreatic cancer cell proliferation through disruption of core histone mRNA processing
RNA · 2024-03 · 30 (3) · 281-297
DOI: 10.1261/rna.079931.123 ↗Kurz gefasst
Fachartikel in der Zeitschrift RNA, online erschienen am 08.01.2024. Verfasst von Abdulrahman A Alahmari und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology and Therapeutics, Roswell Park Comprehensive Cancer Center, Buffalo, New York 14203, USA. Hauptthemen laut MEDLINE: Histones, Pancreatic Neoplasms. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 81 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS.
Abstract (Originalsprache)
Pancreatic ductal adenocarcinoma (PDAC) is a lethal disease with limited effective treatment options, potentiating the importance of uncovering novel drug targets. Here, we target cleavage and polyadenylation specificity factor 3 (CPSF3), the 3′ endonuclease that catalyzes mRNA cleavage during polyadenylation and histone mRNA processing. We find that CPSF3 is highly expressed in PDAC and is associated with poor prognosis. CPSF3 knockdown blocks PDAC cell proliferation and colony formation in vitro and tumor growth in vivo. Chemical inhibition of CPSF3 by the small molecule JTE-607 also attenuates PDAC cell proliferation and colony formation, while it has no effect on cell proliferation of nontransformed immortalized control pancreatic cells. Mechanistically, JTE-607 induces transcriptional readthrough in replication-dependent histones, reduces core histone expression, destabilizes chromatin structure, and arrests cells in the S-phase of the cell cycle. Therefore, CPSF3 represents a potential therapeutic target for the treatment of PDAC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacology and Therapeutics, Roswell Park Comprehensive Cancer Center, Buffalo, New York 14203, USA.
- Department of Medical Laboratory Sciences, College of Applied Medical Sciences, Prince Sattam Bin Abdulaziz University, Alkharj 11942, Saudi Arabia.
- Department of Pediatrics, Baylor College of Medicine, Houston, Texas 77030, USA.
- Program in Quantitative and Computational Biology, Baylor College of Medicine, Houston, Texas 77030, USA.
- Medical Scientist Training Program, Baylor College of Medicine, Houston, Texas 77030, USA.
- Department of Biostatistics and Bioinformatics, Roswell Park Comprehensive Cancer Center, Buffalo, New York 14203, USA.
ORCID-Profile: Abdulrahman A Alahmari, Venkata S Jonnakuti
Förderung
- NCI NIH HHS
Zitieren
APA
Alahmari, A. A., Chaubey, A. H., Jonnakuti, V. S., Tisdale, A. A., Schwarz, C. D., Cornwell, A. C., Maraszek, K. E., Paterson, E. J., Kim, M., Venkat, S., Gomez, E. C., Wang, J., Gurova, K. V., Yalamanchili, H. K., & Feigin, M. E. (2024). CPSF3 inhibition blocks pancreatic cancer cell proliferation through disruption of core histone mRNA processing. RNA, 30(3), 281-297. https://doi.org/10.1261/rna.079931.123
Vancouver
Alahmari AA, Chaubey AH, Jonnakuti VS, Tisdale AA, Schwarz CD, Cornwell AC, et al. CPSF3 inhibition blocks pancreatic cancer cell proliferation through disruption of core histone mRNA processing. RNA. 2024;30(3):281-297. doi:10.1261/rna.079931.123
BibTeX
@article{Alahmari2024,
author = {Alahmari, Abdulrahman A and Chaubey, Aditi H and Jonnakuti, Venkata S and Tisdale, Arwen A and Schwarz, Carla D and Cornwell, Abigail C and Maraszek, Kathryn E and Paterson, Emily J and Kim, Minsuh and Venkat, Swati and Gomez, Eduardo Cortes and Wang, Jianmin and Gurova, Katerina V and Yalamanchili, Hari Krishna and Feigin, Michael E},
title = {CPSF3 inhibition blocks pancreatic cancer cell proliferation through disruption of core histone mRNA processing},
journal = {RNA},
year = {2024},
volume = {30},
number = {3},
pages = {281--297},
doi = {10.1261/rna.079931.123}
}
EUVIMED